SCOPUS 정보 검색 플랫폼

International Journal of Clinical Oncology

Volumn 15, Issue 6, 2010, Pages 583-587

Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: Aa report from the Central Japan Lung Study Group, CJLSG 0503 trial

(10) Usami, Noriyasu a Yokoi, Kohei a Hasegawa, Yoshinori a Taniguchi, Hiroyuki b Shindo, Joe c Yamamoto, Masashi d Suzuki, Ryujiro e Imaizumi, Kazuyoshi a Kondo, Masashi a Shimokata, Kaoru a

a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE (Japan)

b TOSEI GENERAL HOSPITAL (Japan)

c OGAKI MUNICIPAL HOSPITAL (Japan)

d NAGOYA EKISAIKAI HOSPITAL (Japan)

e TOYOHASHI MUNICIPAL HOSPITAL (Japan)

Author keywords

Adjuvant chemotherapy; Carboplatin; Gemcitabine; Non small cell lung cancer; Phase II study

Indexed keywords

CARBOPLATIN; GEMCITABINE;

ADJUVANT THERAPY; ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG ERUPTION; DRUG RESPONSE; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; JAPAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; DEOXYCYTIDINE; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78651105833 PISSN: 13419625 EISSN: None Source Type: Journal
DOI: 10.1007/s10147-010-0118-x Document Type: Article

Times cited : (20)

References (18)

1
- 0030912190
- Revisions in the international system for staging lung cancer
- 1:STN:280:DyaK2szjtVOguw%3D%3D 9187198 10.1378/chest.111.6.1710
- CF Mountain 1997 Revisions in the international system for staging lung cancer Chest 111 1710 1717 1:STN:280:DyaK2szjtVOguw%3D%3D 9187198 10.1378/chest.111.6.1710
- (1997) Chest , vol.111 , pp. 1710-1717
- Mountain, C.F.¹

2
- 20544455590
- Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer
- DOI 10.1056/NEJMoa043623
- T Winton R Livingston D Johnson, et al. 2005 Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancer N Engl J Med 352 2589 2597 1:CAS:528:DC%2BD2MXls1Wqurg%3D 15972865 10.1056/NEJMoa043623 (Pubitemid 41007845)
- (2005) New England Journal of Medicine , vol.352 , Issue.25 , pp. 2589-2597
- Winton, T.¹ Livingston, R.² Johnson, D.³ Rigas, J.⁴ Johnston, M.⁵ Butts, C.⁶ Cormier, Y.⁷ Goss, G.⁸ Inculet, R.⁹ Vallieres, E.¹⁰ Fry, W.¹¹ Bethune, D.¹² Ayoub, J.¹³ Ding, K.¹⁴ Seymour, L.¹⁵ Graham, B.¹⁶ Tsao, M.-S.¹⁷ Gandara, D.¹⁸ Kesler, K.¹⁹ Demmy, T.²⁰ Shepherd, F.²¹ more..

3
- 33747847740
- Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial
- DOI 10.1016/S1470-2045(06)70804-X, PII S147020450670804X
- JY Douillard R Rosell M De Lena, et al. 2006 Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol 7 719 727 1:CAS:528:DC%2BD28Xptlyku7c%3D 16945766 10.1016/S1470-2045(06)70804-X (Pubitemid 44283661)
- (2006) Lancet Oncology , vol.7 , Issue.9 , pp. 719-727
- Douillard, J.-Y.¹ Rosell, R.² De Lena, M.³ Carpagnano, F.⁴ Ramlau, R.⁵ Gonzales-Larriba, J.L.⁶ Grodzki, T.⁷ Pereira, J.R.⁸ Le Groumellec, A.⁹ Lorusso, V.¹⁰ Clary, C.¹¹ Torres, A.J.¹² Dahabreh, J.¹³ Souquet, P.-J.¹⁴ Astudillo, J.¹⁵ Fournel, P.¹⁶ Artal-Cortes, A.¹⁷ Jassem, J.¹⁸ Koubkova, L.¹⁹ His, P.²⁰ Riggi, M.²¹ Hurteloup, P.²² more..

4
- 49049109683
- Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE Collaborative Group
- 18506026 10.1200/JCO.2007.13.9030
- JP Pignon H Tribodet GV Scagliotti, et al. 2008 Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol 26 3552 3559 18506026 10.1200/JCO.2007.13.9030
- (2008) J Clin Oncol , vol.26 , pp. 3552-3559
- Pignon, J.P.¹ Tribodet, H.² Scagliotti, G.V.³

5
- 10444237218
- Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: A meta-analysis of survival outcomes
- DOI 10.1016/j.lungcan.2004.10.014, PII S0169500204005409
- T Le Chevalier G Scagliotti R Natale, et al. 2005 Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes Lung Cancer 47 69 80 1:STN:280:DC%2BD2cnivFakug%3D%3D 15603856 10.1016/j.lungcan. 2004.10.014 (Pubitemid 39643243)
- (2005) Lung Cancer , vol.47 , Issue.1 , pp. 69-80
- Le Chevalier, T.¹ Scagliotti, G.² Natale, R.³ Danson, S.⁴ Rosell, R.⁵ Stahel, R.⁶ Thomas, P.⁷ Rudd, R.M.⁸ Vansteenkiste, J.⁹ Thatcher, N.¹⁰ Manegold, C.¹¹ Pujol, J.-L.¹² Van Zandwijk, N.¹³ Gridelli, C.¹⁴ Van Meerbeeck, J.P.¹⁵ Crino, L.¹⁶ Brown, A.¹⁷ FitzGerald, P.¹⁸ Aristides, M.¹⁹ Schiller, J.H.²⁰ more..

6
- 0042661285
- Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: A phase III randomized trial
- DOI 10.1016/S0169-5002(03)00233-2
- P Zatloukal L Petruzelka M Zemanova, et al. 2003 Gemcitabine plus cisplatin vs gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial Lung Cancer 41 321 331 12928123 10.1016/S0169-5002(03)00233-2 (Pubitemid 36970188)
- (2003) Lung Cancer , vol.41 , Issue.3 , pp. 321-331
- Zatloukal, P.¹ Petruzelka, L.² Zemanova, M.³ Kolek, V.⁴ Skrickova, J.⁵ Pesek, M.⁶ Fojtu, H.⁷ Grygarkova, I.⁸ Sixtova, D.⁹ Roubec, J.¹⁰ Horenkova, E.¹¹ Havel, L.¹² Prusa, P.¹³ Novakova, L.¹⁴ Skacel, T.¹⁵ Kuta, M.¹⁶

7
- 0038460705
- Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer
- DOI 10.1016/S0169-5002(03)00140-5
- P Mazzanti C Massacesi MB Rocchi, et al. 2003 Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer Lung Cancer 41 81 89 12826316 10.1016/S0169-5002(03)00140-5 (Pubitemid 36765487)
- (2003) Lung Cancer , vol.41 , Issue.1 , pp. 81-89
- Mazzanti, P.¹ Massacesi, C.² Rocchi, M.B.L.³ Mattioli, R.⁴ Lippe, P.⁵ Trivisonne, R.⁶ Buzzi, F.⁷ De Signoribus, G.⁸ Tuveri, G.⁹ Rossi, G.¹⁰ Di Lullo, L.¹¹ Sturba, F.¹² Morale, D.¹³ Catanzani, S.¹⁴ Pilone, A.¹⁵ Bonsignori, M.¹⁶ Battelli, T.¹⁷

8
- 0026781518
- Predicting glomerular function from adjusted serum creatinine
- 1:CAS:528:DyaK3sXjsFeqsw%3D%3D 1436333 10.1159/000187054
- MH Gault LL Longerich JD Harnett, et al. 1992 Predicting glomerular function from adjusted serum creatinine Nephron 62 249 256 1:CAS:528: DyaK3sXjsFeqsw%3D%3D 1436333 10.1159/000187054
- (1992) Nephron , vol.62 , pp. 249-256
- Gault, M.H.¹ Longerich, L.L.² Harnett, J.D.³

9
- 0024536437
- Optimal two-stage designs for phase II clinical trials
- DOI 10.1016/0197-2456(89)90015-9
- R Simon 1989 Optimal two-stage designs for phase II clinical trials Control Clin Trials 10 1 10 1:STN:280:DyaL1M7ps1SjsQ%3D%3D 2702835 10.1016/0197-2456(89)90015-9 (Pubitemid 19099520)
- (1989) Controlled Clinical Trials , vol.10 , Issue.1 , pp. 1-10
- Simon, R.¹

10
- 0035397994
- Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest Oncology Group trial
- 1:CAS:528:DC%2BD3MXltlShtb4%3D 11432888
- K Kelly J Crowley PA Bunn Jr, et al. 2001 Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a Southwest Oncology Group trial J Clin Oncol 19 3210 3218 1:CAS:528:DC%2BD3MXltlShtb4%3D 11432888
- (2001) J Clin Oncol , vol.19 , pp. 3210-3218
- Kelly, K.¹ Crowley, J.² Bunn Jr., P.A.³

11
- 0036843105
- Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer
- DOI 10.1200/JCO.2002.02.068
- GV Scagliotti F De Marinis M Rinaldi, et al. 2002 Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer J Clin Oncol 20 4285 4291 1:CAS:528:DC%2BD38Xpt1CjtLs%3D 12409326 10.1200/JCO.2002.02.068 (Pubitemid 35266288)
- (2002) Journal of Clinical Oncology , vol.20 , Issue.21 , pp. 4285-4291
- Scagliotti, G.V.¹ De Marinis, F.² Rinaldi, M.³ Crino, L.⁴ Gridelli, C.⁵ Ricci, S.⁶ Matano, E.⁷ Boni, C.⁸ Marangolo, M.⁹ Failla, G.¹⁰ Altavilla, G.¹¹ Adamo, V.¹² Ceribelli, A.¹³ Clerici, M.¹⁴ Di Costanzo, F.¹⁵ Frontini, L.¹⁶ Tonato, M.¹⁷

12
- 0037050352
- Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
- DOI 10.1056/NEJMoa011954
- JH Schiller D Harrington CP Belani, et al. 2002 Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N Engl J Med 346 92 98 1:CAS:528:DC%2BD38Xkt1OlsQ%3D%3D 11784875 10.1056/NEJMoa011954 (Pubitemid 34438899)
- (2002) New England Journal of Medicine , vol.346 , Issue.2 , pp. 92-98
- Schiller, J.H.¹ Harrington, D.² Belani, C.P.³ Langer, C.⁴ Sandler, A.⁵ Krook, J.⁶ Zhu, J.⁷ Johnson, D.H.⁸

13
- 0042413836
- Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 Study Group
- DOI 10.1200/JCO.2003.12.046
- F Fossella JR Pereira J von Pawel, et al. 2003 Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group J Clin Oncol 21 3016 3024 1:CAS:528:DC%2BD2cXpsVWqt7c%3D 12837811 10.1200/JCO.2003.12.046 (Pubitemid 46606280)
- (2003) Journal of Clinical Oncology , vol.21 , Issue.16 , pp. 3016-3024
- Fossella, F.¹ Pereira, J.R.² Von Pawel, J.³ Pluzanska, A.⁴ Gorbounova, V.⁵ Kaukel, E.⁶ Mattson, K.V.⁷ Ramlau, R.⁸ Szczesna, A.⁹ Fidias, P.¹⁰ Millward, M.¹¹ Belani, C.P.¹²

14
- 33847276516
- Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
- DOI 10.1093/annonc/mdl377
- Y Ohe Y Ohashi K Kubota, et al. 2007 Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan Ann Oncol 18 317 323 1:STN:280:DC%2BD2s%2Fotlaqsw%3D%3D 17079694 10.1093/annonc/mdl377 (Pubitemid 46323100)
- (2007) Annals of Oncology , vol.18 , Issue.2 , pp. 317-323
- Ohe, Y.¹ Ohashi, Y.² Kubota, K.³ Tamura, T.⁴ Nakagawa, K.⁵ Negoro, S.⁶ Nishiwaki, Y.⁷ Saijo, N.⁸ Ariyoshi, Y.⁹ Fukuoka, M.¹⁰

15
- 33746322562
- Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104
- DOI 10.1002/cncr.22024
- N Yamamoto K Nakagawa H Uejima, et al. 2006 Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104 Cancer 107 599 605 1:CAS:528:DC%2BD28Xot1aksb8%3D 16804877 10.1002/cncr.22024 (Pubitemid 44107221)
- (2006) Cancer , vol.107 , Issue.3 , pp. 599-605
- Yamamoto, N.¹ Nakagawa, K.² Uejima, H.³ Sugiura, T.⁴ Takada, Y.⁵ Negoro, S.-I.⁶ Matsui, K.⁷ Kashii, T.⁸ Takada, M.⁹ Nakanishi, Y.¹⁰ Kato, T.¹¹ Fukuoka, M.¹²

16
- 26444584325
- Biweekly administration of cisplatin/gemcitabine in advanced nonsmall cell lung cancer
- DOI 10.1097/01.coc.0000170583.42741.cd
- G Lopez-Vivanco A Viteri R Barcelo, et al. 2005 Biweekly administration of cisplatin/gemcitabine in advanced nonsmall cell lung cancer Am J Clin Oncol 28 501 507 1:CAS:528:DC%2BD2MXhtFKjur3K 16199991 10.1097/01.coc.0000170583. 42741.cd (Pubitemid 41437390)
- (2005) American Journal of Clinical Oncology: Cancer Clinical Trials , vol.28 , Issue.5 , pp. 501-507
- Lopez-Vivanco, G.¹ Viteri, A.² Barcelo, R.³ Munoz, A.⁴ Rubio, I.⁵ Mane, J.M.⁶ Fuente, N.⁷

17
- 35148877261
- A phase i dose escalation study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA nonsmall cell lung cancer
- Tomizawa Y, Ishihara S, Iijima H et al (2007) A phase I dose escalation study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA nonsmall cell lung cancer. Am J Clin Oncol 30:498-502
- (2007) Am J Clin Oncol , vol.30 , pp. 498-502
- Tomizawa, Y.¹ Ishihara, S.² Iijima, H.³

18
- 49049089802
- Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
- 1:CAS:528:DC%2BD1cXpvVWmtLg%3D 18506025 10.1200/JCO.2007.15.0375
- GV Scagliotti P Parikh J von Pawel, et al. 2008 Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer J Clin Oncol 26 3543 3551 1:CAS:528:DC%2BD1cXpvVWmtLg%3D 18506025 10.1200/JCO.2007.15.0375
- (2008) J Clin Oncol , vol.26 , pp. 3543-3551
- Scagliotti, G.V.¹ Parikh, P.² Von Pawel, J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.